Phase I/II Study of Avelumab in Pediatric Cancer Participants
Clinical trial NCT03451825 · TERMINATED
Trial details
- NCT number
- NCT03451825
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-07
- Primary completion
- 2021-07-27
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.